An initial three-component pharmacophore for specific serotonin-3 receptor ligands
- 1 October 1990
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 33 (10) , 2721-2725
- https://doi.org/10.1021/jm00172a007
Abstract
With computer modeling, an initial three-component pharmacophore for specific 5-HT3 receptor ligands ICS-205-930 (1), ondansetron (2), zacopride (3), and 3-[2-(guanidinylmethyl)-4-thiazolyl]indol (4) has been identified. Two parts represent electrostatic interactions, one as a hydrogen-bond-donating interaction and the other as a hydrogen-bond-accepting interaction. The third part is represented by a plane in which the lipophilic aromatic groups align. The generation of the pharmacophore relies on the interactions of these ligands with probe atoms representative of a possible hydrogen-bond donor or hydrogen-bond acceptor within the receptor. A carboxylate oxygen was used as a hydrogen-bond-accepting probe and a serine-like hydroxyl was utilized as a hydrogen-bond-donating probe.This publication has 10 references indexed in Scilit:
- Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonistsJournal of Medicinal Chemistry, 1990
- Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptorsBritish Journal of Pharmacology, 1988
- Characterisation of 5-HT3 recognition sites in membranes of NG 108-15 neuroblastoma-glioma cells with [3H]ICS 205-930Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
- The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonistBritish Journal of Pharmacology, 1988
- Zacopride, a potent 5-HT3 antagonistJournal of Pharmacy and Pharmacology, 1988
- PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONISTThe Lancet, 1987
- Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugsNature, 1985
- A computational procedure for determining energetically favorable binding sites on biologically important macromoleculesJournal of Medicinal Chemistry, 1985
- Effects on Migraine Headache of MDL 72,222, an Antagonist at Neuronal 5-HT Receptors. Double-Blind, Placebo-Controlled StudyCephalalgia, 1985
- TWO KINDS OF TRYPTAMINE RECEPTORBritish Journal of Pharmacology and Chemotherapy, 1957